REPLY: Considerations for Drug Development for Heart Failure

被引：2

作者：

Greene, Stephen J. ^{[1
]}

Gheorghiade, Mihai ^{[1
]}

机构：

[1] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Chicago, IL 60611 USA

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 65卷 / 10期

关键词：

TRIALS;

D O I：

10.1016/j.jacc.2014.11.064

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：1061 / 1062

页数：3

共 5 条

[1]

The Global Health and Economic Burden of Hospitalizations for Heart Failure Lessons Learned From Hospitalized Heart Failure Registries [J].

Ambrosy, Andrew P. ;

Fonarow, Gregg C. ;

Butler, Javed ;

Chioncel, Ovidiu ;

Greene, Stephen J. ;

Vaduganathan, Muthiah ;

Nodari, Savina ;

Lam, Carolyn S. P. ;

Sato, Naoki ;

Shah, Ami N. ;

Gheorghiade, Mihai .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) :1123-1133

[2]

Strategies and Opportunities for Drug Development in Heart Failure [J].

Butler, Javed ;

Fonarow, Gregg C. ;

Gheorghiade, Mihai .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (15) :1593-1594

[3]

Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial [J].

Maggioni, Aldo P. ;

Greene, Stephen J. ;

Fonarow, Gregg C. ;

Boehm, Michael ;

Zannad, Faiez ;

Solomon, Scott D. ;

Lewis, Eldrin F. ;

Baschiera, Fabio ;

Hua, Tsushung A. ;

Gimpelewicz, Claudio R. ;

Lesogor, Anastasia ;

Gheorghiade, Mihai .

EUROPEAN HEART JOURNAL, 2013, 34 (40) :3117-3127

[4]

Matchmaking for the Optimization of Clinical Trials of Heart Failure With Preserved Ejection Fraction [J].

Shah, Sanjiv J. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (15) :1339-1342

[5]

The disconnect between phase II and phase III trials of drugs for heart failure [J].

Vaduganathan, Muthiah ;

Greene, Stephen J. ;

Ambrosy, Andrew P. ;

Gheorghiade, Mihai ;

Butler, Javed .

NATURE REVIEWS CARDIOLOGY, 2013, 10 (02) :85-97

← 1 →